MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells-Reference-Cited by-同舟云学术

MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells

Published:2018-01-15 Issue:5 Volume:14 Page:812-824
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Lee Min-Ho¹,Koh Dahae¹,Na Hyelin¹,Ka Na-Lee¹,Kim Seungsu¹,Kim Hyeon-Ji¹,Hong Sungyoul¹,Shin Young Kee¹²,Seong Je Kyung³,Lee Mi-Ock¹

Affiliation:

1. Department of Pharmacy, College of Pharmacy and Bio-MAX Institute, Seoul National University 1 Gwanak-ro, Gwanak-gu, Seoul, Korea

2. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Gwanak-gu, Seoul, Korea;

3. Laboratory of Developmental Biology and Genomics, College of Veterinary Medicine, Seoul National University and Korea Mouse Phenotyping Center, 1 Gwanak-ro, Gwanak-gu, Seoul, Korea

Funder

National Research Foundation of Korea

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15548627.2017.1388476

Reference49 articles.

1. Global cancer statistics, 2012

2. An update on the medical management of breast cancer

3. Tamoxifen: a most unlikely pioneering medicine